KDELR2, a key driver of non-small cell lung cancer invasion and metastasis, can be effectively targeted by inhibiting matrix metalloproteases to suppress invasion, presenting a potential treatment strategy for non-small cell lung cancer (58). Here, KDELR2 is linked to non-small cell lung carcinoma.